MAPT and Parkinson disease: Nonetheless, Tau binding of [18F]AV-1451 was lower than binding predicted from pathological studies: for instance, Winer et al. reported no differences in the patterns of Tau deposition in 15 cognitively normal PD, 14 cognitively impaired PD, and 49 cognitively normal HC [153].